PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Women\'s and Children\'s Health, Karolinska Institutet at Karolinska University Hospital, Tomtebodavägen 18A, 171 77, Stockholm, Sweden. ulf.andersson@ki.se.\', \'Air Ambulance department, Oslo University Hospital, Oslo, Norway.\', \'Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.\', \'Center for Biomedical Science and Bioelectronic Medicine, Feinstein Institutes for Medical Research, Northwell Health, 350 Community Drive, Manhasset, NY, 11030, USA.\', \'Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 500 Hofstra University, Hempstead, New York, 11030, USA.\', \'Department of Surgery, North Shore University Hospital, Northwell Health, 300 Community Drive, Manhasset, NY, 11030, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s10020-020-00172-4
?:hasPublicationType
?:journal
  • Molecular medicine (Cambridge, Mass.)
is ?:pmid of
?:pmid
?:pmid
  • 32380958
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32380958>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32380958>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all